Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless ofFLT3-ITD status: a report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless ofFLT3-ITD status: a report from the Children's Oncology Group

Published:2014-03-25 Issue:2 Volume:166 Page:254-259
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Tarlock Katherine¹²,Alonzo Todd A.³⁴,Moraleda Pilar P.⁵,Gerbing Robert B.³⁴,Raimondi Susana C.⁴⁶,Hirsch Betsy A.⁴⁷,Ravindranath Yaddanapudi⁴⁸,Lange Beverly⁴⁹,Woods William G.⁴¹⁰,Gamis Alan S.⁴¹¹,Meshinchi Soheil¹²⁴

Affiliation:

1. Clinical Research Division; Fred Hutchinson Cancer Research Center; Seattle WA USA

2. Department of Pediatrics; University of Washington School of Medicine; Seattle WA USA

3. Keck School of Medicine; University of Southern California; Arcadia CA USA

4. Children's Oncology Group; Arcadia CA USA

5. Hematology and Blood and Marrow Transplant Program; Hospital Universitario Central de Asturias; Oviedo Spain

6. Department of Pathology; St. Jude Children's Research Hospital; Memphis TN USA

7. Department of Laboratory Medicine and Pathology; University of Minnesota Medical Center; Minneapolis MN USA

8. Carman and Ann Adams Department of Pediatrics; Division of Hematology/Oncology; Children's Hospital of Michigan; Detroit MI USA

9. Children's Hopital of Philadelphia; Philadelphia PA USA

10. Aflac Cancer Center and Blood Disorders Service; Children's Healthcare of Atlanta; Atlanta GA USA

11. Children's Mercy Hospitals and Clinics; Kansas City MO USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12852/fullpdf

Reference15 articles.

1. Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML;Bornhäuser;Blood,2007

2. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group;Cooper;Cancer,2012

3. Remission rates in childhood acute myeloid leukemia (AML) utilizing a dose-intensive induction regimen with or without gemtuzumab ozogamicin (GO): initial results from the Children's Oncology Group phase III trial, AAML0531;Gamis;Blood (ASH Annual Meeting Abstracts),2010

4. Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment Trials AML10 and 12;Harrison;Journal of Clinical Oncology,2010

5. Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplant;Ishiyama;Leukemia,2012

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

2. Pediatric acute myeloid leukemia: Insight into genetic landscape and novel targeted approaches;Biochemical Pharmacology;2023-09

3. Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors;Cancers;2023-07-06

4. The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia;Experimental Hematology;2023-07

5. Acute myeloid leukemia (AML);Cases in Laboratory Genetics and Genomics (LGG) Practice;2023